D-1702-2012 Class II Terminated
FDA drug recall D-1702-2012 was initiated by Mylan Pharmaceuticals Inc. on Jul 27, 2012 and is designated Class II. Reason for recall: Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg. The recall status is terminated (terminated May 21, 2013). Affected quantity: 960 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 3, 2012
- Initiation Date
- Jul 27, 2012
- Termination Date
- May 21, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 bottles
Product description
Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05
Reason for recall
Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.
Distribution pattern
The product was distributed to KY.
Code information
Lot ZLMM12063, Exp March 2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1702-2012
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026